glp-1 and mash A New Phase in Therapeutics: Resmetirom (THR-β Agonist) Semaglutide (GLP-1 Receptor Agonist) GLP-1 BREAKTHROUGH: FDA APPROVES TREATMENT

Cotter, L., Rae, M., McGough, M., Panchal, N., et al

While patients living with chronic life-threatening conditions like Type 2 diabetes may accept these risks, people using GLP-1 drugs for less life-threatening and severe purposes like obesity may be less forgiving if the side effects outweigh the perceived benefits

Published data from the Phase 3b STRIDE trial reported that Ozempic 1 mg via subcutaneous (SC) injection once weekly improved maximum walking distance by 13% compared to placebo after 52 weeks

A physicians perspective on choosing the right option Dr

Experience the power of a glp1 probiotic that Reclaim control over your eating habits with a formulation that promotes fullness and satisfaction

, Nutrition In addition to resistance training, nutrition plays a key role in muscle preservation